Fig. 4From: Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent—Meclizine HClIn vitro release profiles showing combinations of Geleol® and Compritol® in drug/lipid ratio of 1:2 (F17), 1:3 (F18), combination of Geleol® and CW in drug/lipid ratio of 1:2 (F20) and combination of Geleol®, Compritol® and CW in drug/lipid ratio of 1:2 (F28), and 1:3 (F29) at (a) pH 1.2 (b) pH 4.5 (c) pH 6.8Back to article page